Ocular Melanoma Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
IOVA | F | Iovance Biotherapeutics, Inc. | 2.27 | |
DCTH | C | Delcath Systems, Inc. | 2.49 |
Related Industries: Biotechnology Medical Devices
Related Stock Lists:
Medicine
Melanoma
Oncology
Adoptive Cell Transfer
Antineoplastic Drugs
Biopharmaceutical
Breast And Lung Cancer
Cancer
Cancer Cell
Cancer Immunotherapy
Cancer Immunotherapy Product
Cancer Treatment
Carcinoma
Cell Therapy
Checkpoint Inhibitor
Chemotherapy
Chloride
Cholangiocarcinoma
Clinical Development
Clinical Medicine
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
IDNA | D | iShares Genomics Immunology and Healthcare ETF | 2.38 | |
WDNA | D | WisdomTree BioRevolution Fund | 1.93 | |
BBP | C | BioShares Biotechnology Products Fund | 1.48 | |
CNCR | F | Loncar Cancer Immunotherapy ETF | 1.3 | |
XBI | D | SPDR S&P Biotech ETF | 0.88 |
Compare ETFs
Related Industries:
Biotechnology
Medical Devices
Related Stock Lists:
Medicine
Melanoma
Oncology
Adoptive Cell Transfer
Antineoplastic Drugs
Biopharmaceutical
Breast And Lung Cancer
Cancer
Cancer Cell
Cancer Immunotherapy
Cancer Immunotherapy Product
Cancer Treatment
Carcinoma
Cell Therapy
Checkpoint Inhibitor
Chemotherapy
Chloride
Cholangiocarcinoma
Clinical Development
Clinical Medicine
- Ocular Melanoma
Uveal melanoma is a cancer (melanoma) of the eye involving the iris, ciliary body, or choroid (collectively referred to as the uvea). Tumors arise from the pigment cells (melanocytes) that reside within the uvea giving color to the eye. These melanocytes are distinct from the retinal pigment epithelium cells underlying the retina that do not form melanomas. When eye melanoma is spread to distant parts of the body, the 5-year survival rate is about 15%.
Popular Now
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles